Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03862066 · ClinicalTrials.gov registry record
Memory Phenotype and PD-1 Inhibition Response in Oral Cancer
A clinical trial, sponsored by Medical University of South Carolina.
- Terminated
- Registry status
- 2
- Enrollment target
NCT03862066: Clinical Trial study, sponsored by Medical University of South Carolina.
NCT03862066 is a clinical trial that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03862066 was terminated before completion, sponsored by Medical University of South Carolina.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this research study is collect tissue and blood samples from patients who are having surgery and use those samples in lab studies to see if there are any markers in blood and tissue that can help predict how cancer will react to different treatment. Participants in this study will have a blood sample and tissue samples collected for research. The blood and tissue collected will be tested in the laboratory. The tissue collected will be left over tissue from the standard of care surgery.
Primary Outcome
It is anticipated that there will be 12 successful PDX models developed as part of this study.
Interventions
- OTHER Blood collection
- OTHER Tissue collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-02-08 |
| Est. Completion | 2021-11-22 |
Why NCT03862066 stopped before completion
NCT03862066 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Blood collection is the first listed.
NCT03862066 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03862066 about?
NCT03862066 is a clinical study titled "Memory Phenotype and PD-1 Inhibition Response in Oral Cancer". The purpose of this research study is collect tissue and blood samples from patients who are having surgery and use those samples in lab studies to see if there are any markers in blood and tissue that can help predict how cancer will react to different treatment. Participants in this study will hav...
What is the current status of trial NCT03862066?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2019-02-08. Estimated completion is 2021-11-22.
What interventions are being tested in trial NCT03862066?
The interventions under investigation include: Blood collection (OTHER), Tissue collection (OTHER).
Who is sponsoring clinical trial NCT03862066?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI